Our affiliate system

We are building one organization with affiliates in two regions. Our parent company, now known as Prisma Health, supports both affiliates with overall direction and leadership as we continue to align. We will soon share one brand across the entire organization to better reflect this. The rebranded Palmetto Health-USC Medical Group will continue to operate as a joint venture between the Midlands affiliate and the USC School of Medicine.

Learn More
We are becoming Prisma Health in early 2019
 

ReShape Integrated Dual Balloon System

ReShape® your life. No surgery required.

A revolutionary 12-month program for people who want to lose 30 to 70 pounds.Reshape before and after

Palmetto Health-USC Weight Management Center is proud to be the first center in South Carolina to offer the ReShape® Integrated Dual Balloon System, a non-surgical option that is performed endoscopically.

ReShape is recommended as an option for adult patients who have failed weight loss with diet and exercise alone. Weight loss has been reported to range between 25-70 pounds. This procedure is not covered by insurance.

For more information or to set up an appointment, call us at 803-376-5982.

*Photos provided by ReShape. Not a Palmetto Health-USC Weight Management Center patient. Individual results may vary.


About the ReShape® Integrated Dual Balloon System
ReShape gastric balloon


ReShape is indicated for weight reduction when used in conjunction with diet and exercise, in obese patients with a BMI of 30 – 40 and one or more obesity-related comorbid conditions.
 

Watch now


Comparing ReShape® Dual Balloon System with Orbera® Single Balloon Procedure

A study was conducted by Washington University in St. Louis School of Medicine to evaluate the efficacy and safety of the two systems. They found that:

  • Weight loss achieved was similar between the two system, with a 10% total body weight loss at 20 weeks post placement
  • However, adverse events, such as nausea, vomiting, reflux and abdominal pain occurred more often with the Orbera intragastric balloon
  • And adverse events requiring intervention occurred significantly more often with the Orbera IGB. 

View study results (PDF)

Another study, by JourneyLite of Cincinnati, found that:

  • ReShape patients had much shorter symptom durations for nausea and vomiting.
  • Early retrievals due to intolerance were required twice as often in Orbera patients compared with ReShape patents.

View study results (PDF)


More information

  • No issues related to malnutrition, nutritional deficiencies, or bone disease thus far.
  • Since this procedure is nonsurgical, patients won’t have the usual complications associated with surgical weight loss options.
  • Risk of migration of the balloons, which can lead to stomach or intestinal obstruction, is significantly less than with a single balloon system, as there is an anchoring mechanism to prevent this from happening.
  • Each balloon will be filled with a blue dye (Methylene Blue). If a leak occurs in one or both balloons, it can be detected early by noticing blue-green urine. If this happens, the system can be replaced with a new one free of charge.
  • The apparatus fits better in the stomach compared to a one balloon system. Consequently there is a lower likelihood of post procedure nausea, vomiting, pain, belching, heartburn or bloating.
  • As with any procedure, there are potential risks, including: ulceration, perforation, abdominal pain, nausea, vomiting, bloating, belching, heartburn, dehydration and sore throat. These issues may be severe enough to require early removal of the device.
  • Although the design provides an anti-migration feature, there is the potential risk of device migration and intestinal obstruction. The risk of intestinal obstruction is increased if the device is not removed after six months. If intestinal migration occurs, surgical or endoscopic removal may be required.
  • Since the device is kept for only six months, weight regain can occur if patients did not incorporate lifestyle and dietary changes.
  • The system is placed endoscopically under sedation, so patients are able to leave the hospital the same day but are required to be accompanied by a family member or a friend.

The system is removed after six months and patients are able to go home the same day as long as they are accompanied by a family or friend. Even after the balloon is removed, patients will continue to receive nutritional support and free access to the website for the remaining six months.

For more details about the procedure and to hear patient success stories, visit the ReShape corporate website.

Your help is needed. Consider donating blood.

Register Today
 

Giving hope to others

See More